How iron is handled in the course of heme catabolism: Integration of heme oxygenase with intracellular iron transport mechanisms mediated by poly (rC)-binding protein-2.


Journal

Archives of biochemistry and biophysics
ISSN: 1096-0384
Titre abrégé: Arch Biochem Biophys
Pays: United States
ID NLM: 0372430

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 17 04 2019
revised: 05 08 2019
accepted: 10 08 2019
pubmed: 20 8 2019
medline: 24 3 2020
entrez: 18 8 2019
Statut: ppublish

Résumé

Heme and iron are essential to almost all forms of life. The strict maintenance of heme and iron homeostasis is essential to prevent cellular toxicity and the existence of systemic and intracellular regulation is fundamental. Cytosolic heme can be catabolized and detoxified by heme oxygenases (HOs). Interestingly, free heme detoxification through HOs results in the production of free ferrous iron, which can be potentially hazardous for cells. Recently, the intracellular iron chaperone, poly (rC)-binding protein 2 (PCBP2), has been identified, which can be involved in accepting iron after heme catabolism as well as intracellular iron transport. In fact, HO1, NADPH-cytochrome P450 reductase, and PCBP2 form a functional unit that integrates the catabolism of heme with the binding and transport of iron by PCBP2. In this review, we provide an overview of our understanding of the iron chaperones and discuss the mechanism how iron chaperones bind iron released during the process of heme degradation.

Identifiants

pubmed: 31421070
pii: S0003-9861(19)30282-6
doi: 10.1016/j.abb.2019.108071
pii:
doi:

Substances chimiques

Metallochaperones 0
Poly C 30811-80-4
Heme 42VZT0U6YR
Cytochrome P-450 Enzyme System 9035-51-2
Iron E1UOL152H7
Heme Oxygenase (Decyclizing) EC 1.14.14.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108071

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Izumi Yanatori (I)

Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Japan.

Des R Richardson (DR)

Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Japan; Department of Pathology and Bosch Institute, University of Sydney, Camperdown, Sydney, New South Wales, 2006, Australia.

Shinya Toyokuni (S)

Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Japan.

Fumio Kishi (F)

Kenjinkai Healthcare Corporation, 530 Asa, Sanyo-Onoda Yamaguchi, 757-0001, Japan. Electronic address: fkishi-ygc@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH